News Details

( As on 17/04/2025 14:46)

Alivus Life Sciences - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyAlivus Life Sciences Ltd
2CIN NO.L74900PN2011PLC139963
3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY AA-
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD.
5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No



Name of the Company Secretary: Rudalf Corriea
Designation: Compliance officer and Company Secretary
EmailId: complianceofficer@alivus.com
Name of the Chief Financial Officer: Tushar Mistry
Designation: Chief Financial Officer
EmailId: complianceofficer@alivus.com

Date: 17/04/2025

Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.